Here, we designed and prepared cRGD modified cationic liposomes (cRGD-CL) for the delivery of OC-2 shRNA (pshOC-2) to investigate the effect of OC-2 interference on breast cancer survival, migration and metastasis. The gene discussed is ONECUT2; the disease is breast cancer.